LinkOPH

It is summertime in the northern latitudes, and all is well in the dry eye clinics of North America. Remember how hard it was to be a dry eye doc last winter during the polar vortex? All of your patients felt lousy, and every day you questioned the wisdom of treating dry eye. Now, the weather is warm, the humidity is high, you are between the allergy vortex of the shoulder seasons, and all of your patients are convinced that you are a genius. Be careful, though. The summer clime (Read more...)

emThe use of hydroxycholoroquine, originally developed as an antimalarial drug, is increasing among the general
population for the treatment of a variety of rheumatologic conditions. In this installment of Moran Minute, my
friend, talented col…

Read more →

The past few years have seen a rise of less invasive
glaucoma surgical techniques, including the
emergence of microinvasive glaucoma surgery
(MIGS). With this rise, however, comes questions
over what truly qualifies as a MIGS procedure and wha…

Read more →

Athree-person panel advising the National Cancer
Institute (NCI) recently made a recommendation
that is irresponsible, short-sighted, and
indefensible. So indefensible, in fact, that one
need only look to the NCI’s own definition of cancer t…

Read more →

The only evidence-based way of treating glaucoma
is by lowering intraocular pressure (IOP), and
the primary way of accomplishing this is through
the use of medication in the form of eye drops.
Thus, patients’ adherence to their treatment reg…

Read more →

Glaucoma and dry eye disease (DED) are frequently
comorbid conditions. Both are age
related, with prevalence increasing as age
advances.sup1,2/sup Beyond this age-related association,
however, there is also the potential that long-term
to…

Read more →